Home Pharma China Web Edition Pharma China Archives Online Databases Subscription/Order/Info Event Calendar China Pharma Providers About Us
Location: Home > Pharma China Web Edition    
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Editorials
Commentaries
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor´s Picks
 
 
WiCON International Group
311 Sayre Drive,
Princeton, NJ 08540, USA
Tel/Fax: +1 702-9953905
Email:
info@pharmachinaonline.com

China Head Office
c/o Beijing Jicai PharmTech
Suite B-17D, Oriental Kenzo Plaza
48 Dongzhimenwai Dajie
Dongcheng District
Beijing 100027, China
Tel: +86 10 84476010
Fax: +86 10 84476010
Email:
info@pharmachinaonline.com
 
 
 
News
 
Recent Executive Moves 7/10/2020
State Council Issues Guidance Opinions on Advancing BMI Fund Regu... 7/10/2020
CDE Launches Updated Drug Clinical Trial Registration and Informa... 7/10/2020
CDE Launches Online Application Systems for Breakthrough Medicine... 7/10/2020
Merck's MilliporeSigma Opens its Largest M Lab Collaboration Cent... 7/9/2020
Evive Biotech Meets Endpoints in Global PIII Trial for Novel Chem... 7/9/2020
Asieris Received Chinese Approval to Start a Global Phase III Tri... 7/9/2020
Chinese Alzheimer’s Drug Rebuked Again by Top Local Neurologist 7/9/2020
Roche Launches Collaborative Program in China for Digestive Tract... 7/9/2020
CDE Issues the Guidelines for Format/Style and Collation of Drug ... 7/9/2020
Clover Biopharma Receives $66M from CEPI for COVID-19 Vaccine Can... (free) 7/9/2020
More>>
 
Feature Articles
 
Revisiting the Basis of Your China Strategy in the Post-Covid New... 7/1/2020
Trends in U.S. Multinational Enterprise Activity in China, 2000-2... 7/1/2020
Ex-USPTO Head, Retired Judge Back China Pharma IP Reform 6/30/2020
How Data Protection Matters for Pharma Cos in Mainland China? - E... 6/30/2020
In Depth: Decoding China's First Civil Code 6/23/2020
Dealing with the Chinese Economy after COVID-19 6/3/2020
Chinese Antitrust Authority Imposes Maximum Fine In Rare Abuse Of... 6/1/2020
Despite Stormy Days Ahead, Pockets of Hope and Opportunity Remain... 6/1/2020
Challenges Posed to Chinese Biotechs in Post-Pandemic Era 5/28/2020
Considerations on the Protection of Remdesivir under Trademark La... 5/26/2020
COVID-19 Makes Digital Care the Norm in China 5/21/2020
More>>
 
 
 
 
© Wicon International Group  Support by: www.heightow.com   Site map | Contact Us | Links